Abstract

ObjectivesTo determine if the use of carotid ultrasonography (US) may improve the cardiovascular (CV) risk stratification in patients with ankylosing spondylitis (AS).MethodsA set of 127 consecutive patients without history of...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Cardiovascular risk estimation in young patients with ankylosing spondylitis: A new model based on a prospective study in Constanta County, Romania.
Paris Ionescu ... Adrian Suceveanu
Experimental and therapeutic medicine | VOL. 21
Paris Ionescu, et. al.Paris Ionescu ... Adrian Suceveanu
22 Mar 2021
SAT0408 UTILITY OF CAROTID ULTRASOUND AND FRAMINGHAM RISK SCORE ON DISCRIMINATING CORONARY ARTERY DISEASE IN PATIENTS WITH PSORIATIC ARTHRITIS (PsA)
M Li ... J J W Lee
-
M Li, et. al.M Li ... J J W Lee
01 Jun 2020
POS1017 CARDIOVASCULAR RISK IN DIFFERENT CLINICAL VARIANTS OF SPONDYLOARTHRITIS
A Dadalova ... R Samigullina
-
A Dadalova, et. al.A Dadalova ... R Samigullina
19 May 2021
Detection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound
Javier Rueda-Gotor ... Virginia Portilla
Arthritis Research & Therapy | VOL. 20
Javier Rueda-Gotor, et. al.Javier Rueda-Gotor ... Virginia Portilla
29 Aug 2018
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers